drugset / Trial / NCT00799071
Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to find a dose for a twice daily regimen for posaconazole (PSZ) as prophylactic treatment in children with CGD, based on the PSZ trough level.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-07
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Posaconazole | Small molecule | 40 mg/ml | Oral |